Research Papers:
Clinical and genetic features of lung squamous cell cancer in never-smokers
Metrics: PDF 1947 views | HTML 2355 views | ?
Abstract
Yangle Huang1,*, Rui Wang2,*, Yunjian Pan1,*, Yang Zhang1, Hang Li1, Chao Cheng1, Difan Zheng1, Shanbo Zheng1, Yuan Li1, Xuxia Shen1, Haichuan Hu1, Deng Cai1, Shengfei Wang1, Yawei Zhang1, Jiaqing Xiang1, Yihua Sun1, Jie Zhang1, Haiquan Chen1
1Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai, China
2Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai, China
*These authors contributed equally to this work
Correspondence to:
Jie Zhang, email: [email protected]
Yihua Sun, email: [email protected]
Haiquan Chen, email: [email protected]
Keywords: squamous cell lung cancer, never-smoker, clinicopathological characteristics, genetic features
Received: October 09, 2015 Accepted: March 16, 2016 Published: April 15, 2016
ABSTRACT
To evaluate the importance of specific driver mutations to the development and outcome of lung squamous cell cancer (SQCC) in never-smokers, we assessed the clinicopathological characteristics and outcomes of 597 patients who underwent complete resection of SQCCs. In total, 88 (14.7%) never-smokers and 509 (85.3%) ever-smokers were compared. The never-smokers included more females (42.05% vs. 1.57%, P < 0.001) and more often had a personal history of malignant disease (9.09% vs. 2.36%, P = 0.003). The tumors of never-smokers were more often poorly differentiated (70.45% vs. 53.24%, P = 0.010) and more often contained oncogenic mutations (21.05% vs 11.05%, P = 0.023), particularly EGFR mutations (13.16% vs 3.40%, P = 0.001). Never-smokers also tended to have poorer OS than smokers. Our results suggest lung SQCCs in never-smokers are a subtype distinct from SQCCs occurring in smokers.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 8745